Latest News about covid/19 vaccine
Recent news which mentions covid/19 vaccine
Moderna's Authorized COVID-19 Booster Increases Omicron Neutralizing Antibody Levels 37-Fold
December 20, 2021
Tickers
MRNA
From Benzinga
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
From Benzinga
Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
December 16, 2021
Tickers
VALN
From Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
From Benzinga
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
December 15, 2021
Tickers
GOVX
From Benzinga
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
December 15, 2021
Tickers
OCGN
From Benzinga
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine Protection
December 14, 2021
From Benzinga
Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: Reuters
December 14, 2021
Tickers
NVAX
From Benzinga
Moderna, Australia Collaborate To Bring mRNA Manufacturing To Australia
December 14, 2021
Tickers
MRNA
From Benzinga
FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & Older
December 09, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Shot Provides Partial Protection Against Omicron, Study Shows
December 08, 2021
From Benzinga
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
December 07, 2021
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
From Benzinga
Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab
December 06, 2021
From Benzinga
Moderna's President Hoge Sees 'Reboot' Of Existing Shots If Efficacy Falls 50%: Bloomberg
December 06, 2021
Tickers
MRNA
From Benzinga
Pfizer/BioNTech's COVID-19 Shot Receives Emergency Use Nod In Australia For Kids Aged 5-11 Years
December 06, 2021
From Benzinga
From Benzinga
Europe To Start Deliveries Of Pfizer/BioNTech COVID-19 Shot For Children One Week Ahead Of Plan: Reuters
December 02, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
